Oncology Experience
RadPharm is the most experienced imaging core lab in the cancer drug development market segment. We have successfully partnered with global industry leaders to assist them in bringing life-enhancing oncology drugs to patients around the world in a timely, cost efficient operational model.
Medical Image Management
RadPharm’s experience in the management of medical images for oncology clinical trials is unrivalled and includes medical expertise in most major oncologic tumor types such as:
- Basal Cell
- Bladder
- Bone Mets
- Breast
- Colon
- Colorectal
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neuroendocrine
- Ovarian
- Pancreatic
|
- Prostate
- Renal Cell
- Sarcoma
- Solid tumors
- Gastric
- GIST (Gastrointestinal stromal tumors)
- Glioblastoma Multiforme
- Head and Neck
- Liver
- Lung (Small cell and Non-small cell)
- Thyroid
|
RadPharm employs full-time radiologists, oncologists, and nuclear medicine physicians with a focus on “The Medicine Behind the Image™”. We deliver accurate, credible medical imaging trial data. Our board-certified radiologists and medical oncologists read all radiographic and photographic images - from baseline to completion.
Experience Matters
RadPharm provides comprehensive medical expertise from protocol development through study design to regulatory submission. Our thought-leader physicians are available for consultation in the planning and implementation of the imaging portion of your protocol, including identification and selection of optimal response evaluation criteria and modalities for your study.
We have provided Phase II data, pivotal Phase III data, and/or digital FDA image submissions for 17 NDA or SNDA submissions for various critical oncology indications.
Response Evaluation – Lesion Measurement
 RadPharm continually refines and enhances our technological and regulatory know-how, staying conversant with current industry techniques and assessment criteria standards including:
- RECIST and RECIST 1.1
- EBMT
- Cheson (1996, 1999, 2007)
- CHOI
- WHO
- EORTC (Young)
- Macdonald
- Volumetric Assessment
Modality Expertise
- Angiography
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Nuclear Medicine
- Positron Emission Tomography (PET)
- PET/CT
- Medical Photography
- Single Photon Emission Computed Tomography (SPECT)
- Ultrasound
- X-Ray
Medical and Scientific Leadership
- Permanent, full-time staff of board-certified oncologists, radiologists and nuclear medicine physicians
- Physician involvement from RFP response to study close out
- Significant collaboration with regulatory agencies in developing Independent Review Charter (IRC) standards and submission guidelines
RadPharm's Focus
- Quality, service and results
- Sponsor satisfaction
- Innovative solutions
- On-going process improvement
|
